UBS Maintains a 'Buy' on Medtronic, Inc. (MDT); Probably Still Some Room to Work
Tweet Send to a Friend
UBS maintains a 'Buy' on Medtronic, Inc. (NYSE: MDT) price target of $46.00 (from $45.00).
This article: 83 words
-->
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This article: 83 words
-->
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
